Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003235069 | SCV003933685 | benign | FOXG1 disorder | 2023-04-14 | reviewed by expert panel | curation | The allele frequency of the p.Gly224= variant in FOXG1 is 0.136% in Latino sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). In summary, the p.Gly224= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1). |
Genetic Services Laboratory, |
RCV000145993 | SCV000193142 | uncertain significance | Rett syndrome, congenital variant | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001719916 | SCV000728463 | benign | not provided | 2021-04-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000145993 | SCV000770135 | benign | Rett syndrome, congenital variant | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316932 | SCV000851528 | likely benign | Inborn genetic diseases | 2017-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |